Surfactant–Polymer Nanoparticles Overcome P-Glycoprotein-Mediated Drug Efflux
- 18 August 2007
- journal article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 4 (5), 730-738
- https://doi.org/10.1021/mp070024d
Abstract
Nanoparticles enhance the therapeutic efficacy of an encapsulated drug by increasing and sustaining the delivery of the drug inside the cell. We have previously demonstrated that Aerosol OT (AOT)-alginate nanoparticles, a novel formulation developed recently in our laboratory, significantly enhance the therapeutic efficacy of encapsulated drugs like doxorubicin in drug-sensitive tumor cells. The purpose of this study is to evaluate the drug delivery potential of AOT-alginate nanoparticles in drug-resistant cells overexpressing the drug efflux transporter, P-glycoprotein (P-gp). AOT-alginate nanoparticles were formulated using an emulsion-cross-linking process. Rhodamine 123 and doxorubicin were used as model P-gp substrates. Cytotoxicity of nanoparticle-encapsulated doxorubicin and kinetics of nanoparticle-mediated cellular drug delivery were evaluated in both drug-sensitive and -resistant cell lines. AOT-alginate nanoparticles enhanced the cytotoxicity of doxorubicin significantly in drug-resistant cells. The enhancement in cytotoxicity with nanoparticles was sustained over a period of 10 days. Uptake studies with rhodamine-loaded nanoparticles indicated that nanoparticles significantly increased the level of drug accumulation in resistant cells at nanoparticle doses higher than 200 microg/mL. Blank nanoparticles also improved rhodamine accumulation in drug-resistant cells in a dose-dependent manner. Nanoparticle-mediated enhancement in rhodamine accumulation was not because of membrane permeabilization. Fluorescence microscopy studies demonstrated that nanoparticle-encapsulated doxorubicin was predominantly localized in the perinuclear vesicles and to a lesser extent in the nucleus, whereas free doxorubicin accumulated mainly in peripheral endocytic vesicles. Inhibition of P-gp-mediated rhodamine efflux with AOT-alginate nanoparticles was confirmed in primary brain microvessel endothelial cells. In conclusion, an AOT-alginate nanoparticle system enhanced the cellular delivery and therapeutic efficacy of P-gp substrates in P-gp-overexpressing cells.Keywords
This publication has 26 references indexed in Scilit:
- A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in ratsMolecular Cancer Therapeutics, 2006
- In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumorsJournal of Controlled Release, 2006
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- Alteration of Genomic Responses to Doxorubicin and Prevention of MDR in Breast Cancer Cells by a Polymer Excipient: Pluronic P85Molecular Pharmaceutics, 2005
- Enhanced Antiproliferative Activity of Transferrin-Conjugated Paclitaxel-Loaded Nanoparticles Is Mediated via Sustained Intracellular Drug RetentionMolecular Pharmaceutics, 2005
- Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivoJournal of Hepatology, 2005
- Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumorJournal of Controlled Release, 2005
- Intractable Cancers: The Many Faces of Multidrug Resistance and the Many Targets it Presents for Therapeutic AttackCurrent Drug Targets, 2004
- Molecular and pharmacological strategies to overcome multidrug resistanceExpert Review of Anticancer Therapy, 2001
- The Mechanism of Action of Multidrug-Resistance-Linked P-GlycoproteinJournal of Bioenergetics and Biomembranes, 2001